A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Clinical trial NCT05611671 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05611671
- Sponsor
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2024-11-28
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.